Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder caused by a CAG repeat expansion in the SCA7 gene leading to elongation of a polyglutamine tract in ataxin-7, a protein of unknown function. A putative ataxin-7 yeast orthologue (SGF73) has been recently identified as a new component of the SAGA (Spt/Ada/Gcn5 acetylase) multisubunit complex, a coactivator required for transcription of a subset of RNA polymerase II-dependent genes.
INTRODUCTION
Spinocerebellar ataxia type 7 (SCA7) is a dominantly inherited neurodegenerative disorder, characterized by late-onset neuronal loss in cerebellum, brainstem and retina. SCA7 is caused by a CAG repeat expansion in the SCA7 gene encoding ataxin-7, a 892 amino acids protein of unknown function (1, 2) . Initial sequence analysis only predicted a bipartite nuclear localization signal (NLS) shown to be functional in transfected cells (3) . However, recent bioinformatic studies identified a significant block of homology between human ataxin-7 and a yeast open reading frame, YGL066w (4, 5) , that was recently identified as a novel subunit of the SAGA complex (Spt/Ada/Gcn5 acetylase) and named SGF73 (6, 7) .
The yeast SAGA complex is composed of Ada coactivators, Spt proteins, a subset of yeast TBP-associated factors (TAFs) and Tra1 (8, 9) . Yeast SAGA acts as a transcriptional coactivator/adapter required at specific promoters and possesses a histone acetyltransferase (HAT) activity that is mediated by Gcn5. Human homologues of yeast Gcn5 include PCAF and GCN5 (10, 11) , which were found in several multiprotein complexes, such as TBP-free TAF complex (TFTC) (12) , SPT3-TAF9-GCN5 acetyltransferase complex (STAGA) (13) and PCAF/GCN5 complexes (14) . While still incompletely characterized, these multisubunit complexes show related, but not identical compositions and presumably overlapping but also distinct functions. All contain TRRAP, the human homologue of yeast Tra1, homologues of yeast SAGA subunits and a subset of TAFs, but clearly lack the TATA-binding protein (TBP) (15) . However, TFTC specifically contained TAF5 and TAF6, whose yeast homologues are also found in SAGA, whereas these subunits were not found in STAGA or in PCAF/GCN5 complexes (16) . These complexes contain a GCN5 HAT activity and were shown to preferentially acetylate histone H3 in both free and nucleosomal contexts and to activate transcription on chromatin templates (12, 17, 18) . Furthermore, TFTC was shown to direct preinitiation complex assembly in the absence of transcription factor IID (TFIID) on naked at Pennsylvania State University on http://hmg.oxfordjournals.org/ Downloaded from 4 DNA templates (19) . Recent findings also suggested a role for TFTC/STAGA complexes in DNA repair (17, 20) .
In this study, we demonstrated that ataxin-7 is an integral subunit of highly purified TFTC complex and that an anti-ataxin-7 antibody co-immunoprecipitated TFTC-like complexes and an HAT activity corresponding to that of GCN5. Furthermore, we identified a family of SCA7 genes conserved from human to yeast. Biochemical experiments showed that a highly conserved domain in ataxin-7 was able to bind zinc and was sufficient for interaction with TFTC/STAGA subunits. Finally, we showed that a polyQ expansion in ataxin-7 did not affect TFTC-like complex formation. 
RESULTS

Ataxin-7 is a novel subunit of GCN5 histone acetyltransferase-containing complexes
A putative ataxin-7 yeast orthologue (SGF73, encoded by YGL066w) has recently been identified as a novel subunit of the SAGA complex (7). We thus asked whether human ataxin-7 is also a subunit of TFTC/STAGA complexes which are human homologues of the yeast SAGA complex. In order to test this hypothesis, we performed co-immunoprecipitation (IP) experiments using nuclear extract of HeLa cells. When an anti-ataxin-7 antibody was used to immunoprecipitate ataxin-7-associated proteins, we detected by western blot analysis ataxin-7 and the specific TFTC subunits TRRAP and GCN5 (Fig. 1A , lane 3), whereas these proteins were not detected in a control IP (Fig. 1A, lane 5 ). In addition, the anti-ataxin-7 antibody immunoprecipitated also TAF10, but not TBP. Conversely, an anti-TRRAP antibody immunopurified ataxin-7 together with other human TFTC subunits, as shown by western blot (Fig. 1A , lane 4) and mass spectrometry (data not shown). These results suggest that ataxin-7 is associated with TRRAP in a large multiprotein complex. Importantly, an anti-TBP antibody failed to detect TBP in both ataxin-7-and TRRAP-immunopurified fractions ( These results were further confirmed by using highly purified TFTC preparation (19) . A monoclonal antibody against human ataxin-7 strongly and specifically detected a band at the expected size (110 kDa) in the highly purified TFTC complex (Fig. 1B) . These results together unequivocally confirmed that ataxin-7 is a TFTC/STAGA subunit. 6 TFTC/STAGA complexes contain an histone acetyltransferase (HAT) activity that is mediated by GCN5 (12) . In order to confirm that endogenous ataxin-7 is an integral component of these complexes, we tested the ability of the ataxin-7 immunopurified complex to acetylate free histones using an in vitro assay. This assay was directly performed on sepharose beads after IP. As shown in Fig. 1 C, 
Identification of conserved domains in ataxin-7
As ataxin-7 and SGF73 are part of an important evolutionarily conserved complex acting in eukaryotic transcriptional regulation, we next wanted to determine the pattern of ataxin-7 sequence conservation through evolution and searched for SCA7 homologue genes in various genomes. Four SCA7 paralogue g enes were identified in the human genome and named SCA7, SCA7-L1, SCA7-L2 and SCA7-L3, encoding ATX7, ATX7-L1, ATX7-L2 and ATX7-L3, respectively (Fig. 2) . These genes are unambiguous SCA7 paralogues as they were localized at distinct loci and consistently found in all vertebrate genomes analysed ( H. sapiens, Mus musculus, Brachydanio rerio and Fugu rubripes). Sequence comparison of ATX7 family members revealed two conserved blocks: block I (residues 126-176 in human ATX7) and block II (residues 341-400). A third region (block III, residues 508-565) was conserved in all vertebrate sequences except in ATX7-L3 (Fig. 2A) . The expandable polyQ 7 motif is present and located N-terminal to block I in human ATX7 and in its vertebrate orthologues but is absent in ATX7 paralogues.
Using human ATX7 block I and II as query sequences, we retrieved several ATX7 homologues in more distant species: Ciona intestinalis (not shown), Anophele gambiae, Caenorhabditis briggsae (not shown), S. cerevisiae, S. pombe and N. crassa. In t hese genomes, a single ATX7 sequence was found and characterized by a weakly conserved block I (16% identity between H. sapiens and S. cerevisiae) located N -terminal to a highly conserved block II (42% identity) and by absence of block III ( Fig. 2A) . This pattern and degree of conservation suggest that these yeast proteins are ATX7 orthologues. Interestingly, ATX7-L3 was also characterized by the absence of block III and showed a weaker homology to human ATX7 (34% identity for block II) than SGF73 (42% identity for block II). This suggested that SCA7-L3 might result from an ancient duplication of an ancestral SCA7 gene.
Multiple alignments of the highly conserved block II identified several invariant residues across species allowing the definition of an ATX7 signature, as shown in Fig. 2 C. In particular, block II contained 3 Cys and 1 His (Cys 3 His, black triangles in Fig. 2C ) forming a Cys-X 9-10 -Cys-X 5 -Cys-X 2 -His motif within a specific signature that was only found in ATX7 and its homologues.
Ataxin-7 is a zinc-binding protein
As ataxin-7 block II contained invariant residues with the potential to coordinate metal ions, we next asked whether human ataxin-7 binds a metal through this highly conserved domain.
We constructed an expression vector that enabled the production of an ataxin-7 fragment (residues 311-406) encompassing block II fused to glutathion-S-transferase (GST). After removal of the GST moiety (Fig. 3A) , metal content of the purified recombinant ataxin-7 fragment was analyzed by electrospray ionization-mass spectrometry. Measurements were 8 performed in ammonium acetate for native conditions and in water-acetonitrile with formic acid for denaturing conditions. Under denaturing conditions, we detected one major ionization product of 12,848.7 ± 0.3 Da, fitting with ataxin-7 fragment theoretical mass of 12,848.4 Da (data not shown). Under non-denaturing conditions, we detected one major product of 12,911.5 ± 0.2 Da, revealing the presence of one zinc atom as deduced by comparing molecular m asses obtained from denaturing and native conditions (Fig. 3B) . No other ionization products of higher molecular weight were detected, indicating that this domain was monomeric in these conditions. Together, these results showed that this conserved block II corresponds to a folded zinc-binding domain, confirming the functional relevance of the highly conserved Cys and His residues. This ataxin-7 domain (residues 311-406) is thereafter referred as ataxin-7 zinc-binding domain (ZBD).
Human ataxin-7 zinc-binding domain interacts with TFTC/STAGA subunits
We next wanted to examine whether the highly conserved ZBD could directly recruit TFTC/STAGA complexes. We cloned and expressed the following fusion proteins: GST-ATX7(311-406) which corresponds to the ZBD and GST-ATX7(90-406) encompassing block I and the ZBD (Fig. 4A ). These recombinant proteins were produced and immobilized on glutathione-sepharose beads in parallel with GST alone, as a control. We then tested the ability of these fusion proteins to interact with TFTC/STAGA subunits from HeLa nuclear extract. As shown by western blot analysis (Fig. 4B ), all TFTC/STAGA subunits tested, TRRAP, GCN5 and TAF10, were specifically recruited from nuclear extracts by GST-ATX7(311-406) and by GST-ATX7(90-406), but not by the GST control. In contrast, ataxin-7 ZBD did not interact with TIF1β, which is a factor unrelated to these complexes.
Interestingly, endogenous human ataxin-7, which is expressed at low levels in HeLa cells, was significant ly enriched in the GST-ATX7-bound fraction as compared with the input 9 nuclear extract (NE). This result further suggests that the different GST-ATX7 fusion proteins pull-down entire TFTC-like complexes of which endogenous ataxin-7 is an integral component in HeLa cells.
To further delineate the domain interacting with TFTC subunits, we performed successive deletions of the GST-ATX7(311-406) initial construct, removing the weakly conserved residues in the ZBD N-and C-terminal ends. Using 5 deletion construc ts (Fig. 4A ), we defined a minimal ZBD (330-401) that is sufficient to pull-down GCN5 and TAF10 (Fig. 4C) .
Polyglutamine expansion in ataxin -7 does not affect TFTC-like complex formation
The SCA7 mutation is an expansion of a polyglutamine (polyQ) tract in ataxin-7 N-terminal part ( First, we wanted to determine whether the polyQ expansion would affect the association of ataxin-7 with TFTC/STAGA complexes. We performed co-IP experiments using whole cell extracts of HEK293 cells transfected with constructs expressing FLAG-tagged full-length ataxin-7 carrying either 10 or 60 glutamines. Anti-FLAG immunoprecipitated fractions were analyzed by western blot analysis. Interestingly, normal and mutant ataxin-7 equally interacted with the TFTC subunits TRRAP, GCN5 and TAF10 (Fig. 5A ). These proteins were not detected after anti-FLAG IP performed on mock transfected HEK293 cells (Fig. 5A ).
Normal and mutant recombinant ataxin-7 were specifically and efficiently immunoprecipitated using anti-FLAG antibody. In order to confirm this result in vivo, we performed co-IP experiments using lymphoblastoid cell lines, derived from a SCA7 patient, at Pennsylvania State University on http://hmg.oxfordjournals.org/ Downloaded from expressing both normal (10 Q) and mutant (51 Q) ataxin-7 (Fig. 5B, lane 1) . Both normal and mutant ataxin-7 were specifically immunoprecipitated from nuclear extracts of SCA7 cells with an anti-TRRAP (Fig. 5B, lane 2) or with an anti-ATX7 antibody (Fig. 5B, lane 3) . The bands corresponding to normal and expanded ataxin-7 were of comparable intensities in both TRRAP and ataxin-7 IPs, indicating that both forms of ataxin-7 are equally incorporated within TFTC/STAGA complexes in SCA7 cells. Two percent of the amount of nuclear extract used for IP were loaded on the gel (Fig. 5B, lane 1) and revealed that endogenous ataxin-7 was significantly enriched after TRRAP IP (Fig. 5B, lane 2) . Furthermore, we performed an anti-TRRAP IP using nuclear extracts from SCA7 cells used in Figure 5B or from control lymphoblastoid cells derived from an unaffected individual, only expressing normal ataxin-7.
Western blot analysis of TRRAP-associated proteins showed that GCN5 and TAF10 were similarly immunopurified from both cell lines (Fig 5C, lanes 2 and 3) . Ten percent of the amount of nuclear extract used for IP were loaded on the gel (Fig. 5C, lane 1) and revealed that endogenous TRRAP was efficiently enriched after IP (Fig. 5C, lane 2) , in both the control and the SCA7 cell line. These results together indicate that TFTC/STAGA subunit composition is not altered by polyQ expansion in ataxin-7.
We then investigated whether expanded ataxin-7 would recruit and sequester TFTC/STAGA subunits into NIs. We transfected truncated SCA7 cDNA constructs with 10 or 60 CAG encompassing block I, the ZBD and the NLS. Immunostaining revealed that normal and mutant recombinant ataxin-7 were exclusively localized in the nucleus from HeLa (Fig. 5B) , COS-1, NIH-3T3 and HEK293 cells (data not shown), confirming that the predicted bipartite NLS is functional in these cells. This result is surprisingly contradictory with a recent study suggesting that this NLS was not functional by using a comparable ataxin-7 construct (residues 1 -460) in transfection experiments using HEK293 cells (21) . Mutant ataxin-7 (residues 1-456) either displayed a diffuse nuclear staining or accumulated into large NIs (Fig. 
DISCUSSION
Identification and multiple alignments of ATX7 homologues revealed significant conservation of three blocks. Block II is highly conserved through evolution, from human t o yeast, and allowed us to define an ATX7 signature (Fig. 2C) . Notably, we noticed strictly conserved Cys and His forming a Cys-X 9-10 -Cys-X 5 -Cys-X 2 -His motif that exhibits similarities with the Nup475 family consensus sequence (Cys-X 8 -Cys-X 5 -Cys-X 3 -His). T his domain has been previously shown to coordinate zinc through the conserved Cys and His residues and to fold into a new structural zinc-finger motif (22, 23) . Nup475 structure revealed a mainly extended region stabilized by zinc coordination and two hydrophobic cores. Secondary structure prediction of ataxin-7 block II revealed a nearly complete lack of regular secondary structural elements (data not shown). Despite the presence of a zinc coordination unit, as demonstrated by mass spectrome try (Fig. 3) , absence of any stabilizing hydrophobic interactions in ataxin-7 block II suggested that it forms a novel zinc-binding fold. Furthermore, ataxin-7 block II consensus sequence is markedly different from that of the Nup475 family, except the Cys 3 His motif. Resolution of ataxin-7 block II three-dimensional structure should elucidate the folding of this atypical zinc-finger motif. Further experiments are also required to determine which residues bind zinc and whether zinc-binding is necessary for ataxin-7 incorporation into TFTC/STAGA complexes. The highly conserved residues in ataxin-7 block II between yeast SGF73 and mammalian ATX7s and the lack of high homology in their other domains suggest that these residues are involved in ataxin-7 architecture and/or interaction with other TFTC/STAGA subunits.
Block I is less conserved (16% identity between human and yeast) but is characterized by a high conservation of Cys and His forming a Cys-X 2 -Cys-X 11 -His-X 3-4 -His/Cys motif (Fig.   2B ), which is reminiscent of C 2 H 2 zing-finger motifs although with a different spacing (24) .
Block III was only found in vertebrates ATX7, ATX7-L1 and ATX7-L2 and is characterized at Pennsylvania State University on http://hmg.oxfordjournals.org/ Downloaded from 13 by presence of several aromatic, charged and polar residues. However it did not match any previously described motif (Fig. 2D) . Function of blocks I and III remains to be elucidated, in particular whether these domains are also involved in interaction with specific TFTC/STAGA subunits. In agreement, several subunits have been shown to interact with distinct partners within these complexes (25).
Immunoprecipitation of endogenous ataxin-7 from HeLa cells specifically retrieved TFTC/STAGA subunits together with a GCN5 characteristic HAT activity. Accordingly, ataxin-7 did not interact with TBP which is specific for the TFIID transcriptional complex.
Altogether, these results demonstrate that ataxin-7 is a novel subunit of TFTC-like complexes and is the orthologue of the yeast SAGA-associated factor SGF73 ( Table 1) . We have shown that ataxin-7 zinc-binding domain (block II, residues 330-401) is sufficient to pull-down these complexes. It remains to be determined which subunit(s) directly interact with this domain and whether ataxin-7 is required for TFTC/STAGA integrity and activity. Ataxin-7 is the fourth member of the polyQ disease genes, besides the androgen receptor, the TATA-binding protein and atrophin-1 (27) , which normal function is involved in transcriptional regulation. Interestingly, recent findings indicate that transcriptional dysregulation contribute to the pathogenesis of polyQ-induced neuronal dysfunction (28, 29) and might be mediated by defects in histone acetylation. This hypothesis is based on the observations that CREB-binding protein HAT activity is impaired by expanded polyQ in vitro We demonstrated that both normal and mutant ataxin-7 can be incorporated in TFTC/STAGA complexes immunopurified from SCA7 patient cell lines and that the incorporation of mutant ataxin-7 did not alter the composition of TFTC/STAGA complexes. It will thus be of major interest to assess HAT activity from TFTC/STAGA complexes containing either normal or mutant ataxin-7. A decreased HAT activity of mutant ataxin-7 containing complexes is unlikely to occur as a partial loss of ataxin-7 function does not appear to contribute to SCA7 pathogenesis. Thus, a polyQ expansion in these complexes could either lead to an increased HAT activity or to a non-regulated transcriptional activity of the TFTC/STAGA complexes. 
MATERIALS AND METHODS
Sequence analysis
We have used the two core domains (block I and block II) of human ataxin-7 (ATX7) as query sequences in BLAST (37) searches in the SwissProt/TrEMBL protein sequences databases and in various genomes. We introduced the following nomenclature for human ATX7 paralogues: ATX7-L1 for KIAA1218, ATX7-L2 for FLJ00381 and ATX7-L3 for FLJ31440. Sequences were then aligned using ClustalX (38) and the figure was generated with Alscript 2.04 (39) . Secondary structure of ataxin-7 block II was calculated using the PHD program (40).
Plasmids construction and GST pull-down assays
For cell transfection experiments, full-length SCA7 cDNAs with either 10 or 60 CAGs were obtained by PCR amplification of respectively pαaIA and pαbIA constructs (41), using a 5' primer encoding a FLAG epitope. These fragments were subcloned into pcDNA3.1(+) (Invitrogen) to generate pc7NFL and pc7EFL. Truncated SCA7 constructs (pc7N456 and pc7E456) were generated by PCR amplification of pc7NFL and pc7EFL and re-introduced into pcDNA3.1(+) vector (Invitrogen). Block I and II SCA7 constructs (ATX7(311-406), (90-406), (323-401), (330-401), (337-401), (330-389) and (330-377)) were generated by PCR amplification of pc7NFL and introduced into the pGEX-4T-1 plasmid (Amersham Pharmacia Biotech). These constructs were expressed in Escherichia coli BL21 (DE3) strain and purified according to manufacturer's instructions. Fusion proteins bound to glutathione-sepharose beads were incubated with nuclear extracts of HeLa cells in lysis buffer (50 mM Tris-HCl pH7.9, 10% glycerol, 1 mM EDTA, 150 mM NaCl, 5 mM MgCl 2 , 0.1% NP40, and protease inhibitors. After extensive washing, bound proteins were analyzed by Western blot.
Mass spectrometry measurements
Affinity purified GST-ATX7(311-406) was recovered by elution with glutathione (GSH) and further purified by Fast Performance Liquid Chromatography on a Pharmacia Superdex S200(16/90) gel-filtration column in a buffer with 10mM Tris-HCl pH7.5 and 150 mM NaCl.
1 unit of bovine thrombin (Sigma T-6634) was added for 72 hours in order to cleave the GST, which was finally removed by affinity on GSH-sepharose beads. The flow through containing ATX7(311-406) was then dialysed against 200 mM ammonium acetate (pH 7.0), concentrated with Centricon 3kDa (Millipore) and submitted to electrospray ionization-time of flight (ESITof) mass spectrometry (LCT, Waters, UK). Samples were diluted to 10 pmol/µl in 50 mM ammonium acetate buffer and continuously infused into the ESI ion source at a flow rate of 6 µl/min through a Harvard syringe pump. Parameters were optimised so that non covalent interactions survives the ionization/desorption process. The accelerating voltage, which controls the kinetic energy communicated to the ions in the i nterface region of the mass spectrometer, was set to 120 V, and the pressure to 5 mbar. ESI-MS data were acquired in the positive ion mode on the mass range 500-4000 m/z. Calibration of the instrument was performed by using the multiply charged ions produced by a separate injection of horse heart myoglobine diluted to 2 pmol/ul in a 1:1 water-acetonitrile mixture (v/v) acidified with 1% of formic acid.
Western blot, immunoprecipitations and HAT assays
The anti-TRRAP polyclonal (1930) and monoclonal (2TRR-2D5) antibodies were generated by immunization of rabbits and mice with peptides corresponding to aminoacids 198-219 (VKVNPEREDSETRTHSIIPRGS) and 2005-2024 (DQQPDSDMDPNSSGEGVNSV) of human TRRAP, respectively, as described (20) . Western blot were performed as described using anti-ataxin-7 (41), anti-TIF1β (42), anti-GCN5 (20) , anti-TAF10 and anti-TBP (19) 18 monoclonal antibodies. immunoprecipitations were carried out using anti-ataxin-7 (1261 (41)) and anti-TRRAP (1930) polyclonal antibodies as described (20) . Protein complexes bound to protein A-sepharose beads were either boiled and processed for western blot analysis or used for HAT assays, as described (12) . TFTC complex was purified as previously described (19) . 
Cell transfection and immunocytofluorescence
